suPAR is a potential biomarker for triage of patients with COVID-19 symptoms in the ED

Tue Mar 30 2021

Soluble urokinase plasminogen activator receptor as a decision marker for early discharge of patients with COVID-19 symptoms in the emergency department

published in The Journal of Emergency Medicine

A newly published paper written ED doctors shows that suPAR is a potential biomarker for triage and safe early discharge of patients with COVID-19 symptoms in the ED. suPAR can even be used even before SARS-CoV-2 status is known.

SARS-CoV-2 strains healthcare capacity. Better risk stratification, with discharge of patients with a predicted mild disease trajectory, can ease this burden. Elevated suPAR has previously been shown associated with risk of intubation in confirmed COVID-19 patients.

386 patients were included strengthening the paper’s COVID-19 conclusions, as well as the notion that suPAR is a biomarker that can help ED physicians decide whether a patient should be admitted or, in fact, can safely be discharged.

This helps reducing crowding in the ED and may thus allow overburdened COVID-19 staff across our hospitals to get a five-min break during their current COVID-19 24/7 schedules.

suPAR is a potential biomarker for triage and safe early discharge of patients with COVID-19 symptoms in the ED.

– Stauning et al, Journal of Emergency Medicine, March 2021

900+

published suPAR studies in leading medical journals

Nature Medicine Logo
Science Journal Logo
JAMA Pediatrics Logo

The suPARnostic® brand consists of 4 products:

Quick Triage

A Point of Care Solution

TurbiLatex

For Automated Systems

ELISA Assay

Clinical and Research

suPARnostic POC+

POC+

Point-of-care finger prick

suPAR is used in clinical routine in 48 hospitals

48 hospitals use suPAR in clinical routine for triage of patients in the Emergency Departments and COVID-19 units. Clinical routine is defined by the placement of two Purchasing Orders within the last 12 months rolling.
This period covers January 1, 2022, until December 31, 2022. Some hospital locations cannot be disclosed due to confidentiality.

New Webinar

Webinar

Catch COVID-19

-Improve your triage

Sign up to view webinar recording

View recording

suPARnostic® by ViroGates